BrUOG 337: Olaparib Prior to Radical Prostatectomy For Advanced Prostate Cancer Defects in DNA Repair Genes

PHASE2TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

May 25, 2018

Primary Completion Date

December 15, 2020

Study Completion Date

December 7, 2021

Conditions
Prostate CancerAdenocarcinoma of the Prostate
Interventions
DRUG

Olaparib Pill

300 mg BID

PROCEDURE

Prostatectomy

22-42 days post Olaparib patients will undergo surgery

Trial Locations (1)

02903

Lifespan Cancer Institute: The Miriam and Rhode Island Hospitals, Providence

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Rhode Island Hospital

OTHER

collaborator

The Miriam Hospital

OTHER

collaborator

AstraZeneca

INDUSTRY

lead

Brown University

OTHER